tiprankstipranks
Trending News
More News >
Greenway Greenhouse Cannabis Corp. (TSE:GWAY)
:GWAY
Canadian Market

Greenway Greenhouse Cannabis Corp. (GWAY) AI Stock Analysis

Compare
1 Followers

Top Page

TS

Greenway Greenhouse Cannabis Corp.

(GWAY)

Rating:44Neutral
Price Target:
The overall score reflects significant revenue growth and strategic corporate actions but is weighed down by financial strain and technical bearish trends. The financial performance remains a key concern with high leverage and cash flow issues, while technical indicators suggest caution. Positive corporate events offer potential upside if financial weaknesses are addressed.

Greenway Greenhouse Cannabis Corp. (GWAY) vs. iShares MSCI Canada ETF (EWC)

Greenway Greenhouse Cannabis Corp. Business Overview & Revenue Model

Company DescriptionGreenway Greenhouse Cannabis Corporation engages in the cultivation, processing, and selling of dried cannabis flower and kief. The company was incorporated in 2018 and is based in Kingsville, Canada. Greenway Greenhouse Cannabis Corporation is a subsidiary of Sunrite Greenhouses Ltd.
How the Company Makes MoneyGreenway Greenhouse Cannabis Corp. generates revenue primarily through the sale of its cannabis products to various markets, including medical dispensaries and recreational retailers. The company utilizes its state-of-the-art greenhouse facilities to produce cannabis efficiently and sustainably, reducing costs and enhancing product quality. Revenue streams include the sale of dried cannabis flowers, oils, and other derivative products. Key partnerships with distributors and retailers help expand the company's reach and market presence, contributing significantly to its earnings. Additionally, Greenway may engage in strategic collaborations or white-label agreements to further diversify its revenue sources.

Greenway Greenhouse Cannabis Corp. Financial Statement Overview

Summary
Greenway Greenhouse Cannabis Corp. shows significant revenue growth but faces challenges with profitability and cash flow. High leverage and negative earnings margins highlight financial strain, while cash flow issues threaten operational sustainability. Addressing these areas is crucial for financial health improvement.
Income Statement
40
Negative
The company shows a negative gross profit margin and net profit margin in the TTM, indicating difficulty in covering costs. Revenue has grown significantly from the previous year, suggesting potential market expansion. However, the negative EBIT and EBITDA margins reflect operational inefficiencies.
Balance Sheet
45
Neutral
The debt-to-equity ratio is high, indicating significant leverage, and the equity ratio shows low equity relative to total assets. ROE is negative due to net losses, highlighting profitability challenges. The balance sheet reflects a risk of financial instability.
Cash Flow
30
Negative
Free cash flow is negative, and both operating and free cash flow to net income ratios are unfavorable, indicating cash flow issues. The growth rate of free cash flow is not positive, suggesting the company struggles to generate cash from operations.
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue7.36M5.23M5.62M1.98M0.000.00
Gross Profit-419.25K-335.38K741.99K844.02K487.88K-465.31K
EBITDA-780.49K-2.21M-632.92K-1.36M-727.12K-1.57M
Net Income-3.59M-4.72M-2.61M-2.92M-1.23M-2.18M
Balance Sheet
Total Assets31.62M33.09M35.30M35.63M25.11M17.61M
Cash, Cash Equivalents and Short-Term Investments2.16M1.53M3.64M7.48M3.46M1.44M
Total Debt15.85M16.02M13.96M16.67M13.85M8.00M
Total Liabilities21.86M21.17M20.36M18.77M14.85M8.74M
Stockholders Equity9.76M11.92M14.95M16.86M10.26M8.87M
Cash Flow
Free Cash Flow-732.92K-4.96M-4.38M-4.10M-5.95M-5.53M
Operating Cash Flow-32.11K-2.05M2.23M-1.97M-592.08K-441.11K
Investing Cash Flow-700.81K-2.92M428.31K-2.12M-5.36M-5.09M
Financing Cash Flow537.50K2.85M-6.49M8.12M7.97M5.82M

Greenway Greenhouse Cannabis Corp. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.25
Price Trends
50DMA
0.20
Positive
100DMA
0.22
Positive
200DMA
0.29
Negative
Market Momentum
MACD
0.01
Negative
RSI
83.33
Negative
STOCH
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GWAY, the sentiment is Positive. The current price of 0.25 is above the 20-day moving average (MA) of 0.21, above the 50-day MA of 0.20, and below the 200-day MA of 0.29, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 83.33 is Negative, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:GWAY.

Greenway Greenhouse Cannabis Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (72)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
€3.48B23.4623.09%2.44%32.58%18.20%
TSOGI
71
Outperform
$255.72M18.354.76%26.93%
65
Neutral
$1.06B15.414.61%38.16%
TSACB
50
Neutral
$348.73M106.523.05%16.39%-98.10%
47
Neutral
$338.50M-122.10%-16.27%
44
Neutral
C$34.20M-31.24%44.21%21.93%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:GWAY
Greenway Greenhouse Cannabis Corp.
0.26
-0.03
-10.34%
TSE:WEED
Canopy Growth
1.76
-6.81
-79.46%
TSE:CRON
Cronos Group
2.76
-0.32
-10.39%
TSE:ACB
Aurora Cannabis
6.21
-0.53
-7.86%
TSE:OGI
OrganiGram Holdings
1.91
-0.25
-11.57%

Greenway Greenhouse Cannabis Corp. Corporate Events

Business Operations and StrategyFinancial Disclosures
Greenway Greenhouse Cannabis Reports Strong Q3 Growth Amid Rising Cannabis Prices
Positive
Feb 27, 2025

Greenway Greenhouse Cannabis Corporation reported a 21% increase in net revenue for the third quarter of 2025, compared to the same period in 2024, reaching $1,676,721. The company also saw a 57% increase in net revenue for the nine months ending December 31, 2024, surpassing the previous full fiscal year. The company attributes its growth to rising cannabis prices and the successful launch of new products and brands in the Canadian recreational market. Greenway’s MillRite brand maintained its strong market position, and the company is looking to expand its distribution both domestically and internationally as the Canadian cannabis industry rebounds.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 22, 2025